Combined effects of cold and somatostatin on glucose kinetics in dogs

  • Y. Minaire
  • J. Forichon
  • G. Dallevet
  • M. J. Jomain


The role of the endocrine pancreas in glucose production (Ra), utilization (Rd), and metabolic clearance (R'd) was investigated during acute exposure to cold in normal normothermic dogs. Two ambient temperatures (TaN=+25‡ C and TaC=−21‡ C) were selected. At TaC, metabolic rate and glucose turnover of the shivering dogs were 4.3 and 2.4 times, respectively, higher than in dogs resting at TaN. As compared with the pre-experimental period, somatostatin infusion at TaN induced a 25% (arterial) and 34% (portal) glucagon deficiency, while insulin concentration dropped by 59% (arterial) and 74% (portal). Similar values were obtained at TaC for glucagon (39% arterial and 47% portal) and for insulin (52% arterial and 56% portal). At TaN, these simultaneous hormonal alterations provoked a slight reduction in plasma glucose concentration which levelled down to 4.4 mM. This reduction was due to a decrease in Ra, followed by a parallel decrease in Rd whereas R'd remained unchanged. At TaC, plasma glucose concentration dropped to the same level but quickly rose again during somatostatin infusion. This rise was due to a larger reduction in Rd than in Ra, accompanied by an abrupt fall in R'd. This reduction in R'd appears to be an important mechanism able to restore euglycemia during global pancreatic hormone deficiency in cold exposed dogs.

Key words

Cold Glucose Insulin Glucagon Somatostatin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abramson EA, Arky RA (1968) Role of beta adrenergic receptors in counterregulation of insulin-induced hypoglycemia. Diabetes 17: 141–146Google Scholar
  2. Alberti KG, Christensen NJ, Christensen SE, Hansen AP, Iversen J, Lundbaek K, Seyer-Hansen K, Orskov H (1973) Inhibition of insulin secretion by somatostatin. Lancet 2: 1299–1301Google Scholar
  3. Altszuler N, Barkai A, Bjerknes C, Gottlieb B, Steele R (1975) Glucose turnover values in the dog obtained with various species of labelled glucose. Am J Physiol 229: 1662–1667Google Scholar
  4. Altszuler N, Gottlieb B, Hampshire J (1976) Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog. Diabetes 25: 116–121Google Scholar
  5. Blauth CIA, Sönksen PH, Tompkins CV, Bloom SR (1977) The hypoglycaemic action of somatostatin in the anaesthetized dog. Clin Endocrinol 6: 17–25Google Scholar
  6. Cherrington AD, Chiasson JL, Liljenquist JE, Jennings AS, Keller U, Lacy WW (1976) The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J Clin Invest 58: 1407–1418Google Scholar
  7. Cherrington AD, Lacy WW, Chiasson JL (1978) Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest 62: 664–677Google Scholar
  8. Cherrington AD, Liljenquist JE, Shulman GI, Williams PE, Lacy WW (1979) Importance of hypoglycemia-induced glucose production during isolated glucagon deficiency. Am J Physiol 236: 263–271Google Scholar
  9. Christensen SE, Hansen AP, Iversen J, Lundbaek K, Orskov H, Seyer-Hansen K (1974) Somatostatin as a tool in studies of basal carbohydrate and lipid metabolism in man: modifications of glucagon and insulin release. Scand J Clin Lab Invest 34: 321–325Google Scholar
  10. De Bodo RC, Steele R, Altszuler N, Dunn A, Bishop JS (1963) On the hormonal regulation of carbohydrate metabolism studies with 14C-glucose. Rec Progr Horm Res 19: 445–488Google Scholar
  11. Depocas F, Minaire Y (1969) Chronic vascular cannulation in the dog. Can J Physiol Pharmacol 47: 492–493Google Scholar
  12. Depocas F, Minaire Y, Chatonnet J (1969) Rates of formation and oxidation of lactic acid in dogs at rest and during moderate exercise. Can J Physiol Pharmacol 47: 603–610Google Scholar
  13. Feldman J, Plonk J, Bivens C (1975) The role of cortisol and growth hormone in the counterregulation of insulin-induced hypoglycemia. Horm Metab Res 7: 378–381Google Scholar
  14. Forichon J, Jomain MJ, Dallevet G, Minaire Y (1977) Effect of cold and epinephrine on glucose kinetics in dogs. J Appl Physiol 43: 230–237Google Scholar
  15. Gerich J, Davis J, Lorenzi M, Rizza R, Bohannon N, Karam J, Lewis S, Kaplan R, Schultz T, Cryer P (1979) Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. Am J Physiol 236: 380–385Google Scholar
  16. Gerich J, Lovinger R, Grodsky G (1974) Inhibition of glucagon (IRG) and insulin (IRI) release from the in vitro perfused rat pancreas by somatostatin. 56th Meeting of Endocrine Society Atlanta, p 270Google Scholar
  17. Heding LG (1971) Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia 7: 10–19Google Scholar
  18. Issekutz B Jr, Allen M (1971) Effect of methylprednisolone on carbohydrate metabolism of exercising dogs. J Appl Physiol 31: 813–818Google Scholar
  19. Issekutz B Jr (1978) The role of Β-adrenergic receptors in the mobilization of energy sources in exercising dogs. J Appl Physiol 44: 869–876Google Scholar
  20. Issekutz B Jr, Vranic M (1980) Role of glucagon in regulation of glucose production in exercising dogs. Am J Physiol 238: 13–20Google Scholar
  21. Kepler D, Decker K (1974) Glycogen determination with amyloglucosidase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Verlag Chemie, Weinheim/Academic Press, New York London, pp 1127–1131Google Scholar
  22. Koerker DJ, Ruch W, Chideckel E, Palmer J, Goodner CJ, Ensinck J, Gale CC (1974) Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 184: 482–483Google Scholar
  23. Lefebvre PJ, Luyckx AS (1977) Factors controlling gastric-glucagon release. J Clin Invest 59: 716–722Google Scholar
  24. Lefebvre PJ, Luyckx AS (1978) Glucose and insulin in the regulation of glucagon release from the isolated perfused dog stomach. Endocrinology 103: 1579–1583Google Scholar
  25. Lickley HLA, Ross GG, Vranic M (1979) Effects of selective insulin or glucagon deficiency on glucose turnover. Am J Physiol 236: 255–262Google Scholar
  26. Minaire Y, Pernod A, Jomain MJ, Mottaz M (1971) Lactate turnover and oxidation in normal and adrenal demedullated dogs during cold exposure. Can J Physiol Pharmacol 49: 1063–1070Google Scholar
  27. Minaire Y, Pernod A, Vincent-Falquet JC, Mottaz M (1973a) Comparison of carbohydrate utilization in running and shivering dogs. Horm Metab Res 5: 80–83Google Scholar
  28. Minaire Y, Vincent-Falquet JC, Pernod A, Chatonnet J (1973b) Energy supply in acute cold exposed dogs. J Appl Physiol 35: 51–57Google Scholar
  29. Mortimer CH, Turnbridge WMG, Carr D, Yeomans L, Coy T, Bloom SR, Kastin A, Mallinson CN, Besser GM, Schally AV, Hall R (1974) Effects of growth hormone release inhibiting hormone on circulating glucagon, insulin and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet 2: 697–701Google Scholar
  30. Norwich KH, Radziuk J, Lau D, Vranic M (1974) Experimental validation of non-steady rate measurements using a tracer infusion method and insulin as tracer and tracee. Can J Physiol Pharmacol 52: 508–521Google Scholar
  31. Rizza RA, Cryer PE, Haymond MW, Gerich JE (1980) Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 65: 682–689Google Scholar
  32. Ross G, Lickley L, Vranic M (1978) Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs. Am J Physiol 234: 213–219Google Scholar
  33. Sacca L, Sherwin R, Felig P (1979) Influence of somatostatin on glucagon- and epinephrine-stimulated hepatic glucose output in the dog. Am J Physiol 236: 113–117Google Scholar
  34. Sakurai N, Dobbs R, Unger RH (1974) Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs. J Clin Invest 54: 1395–1402Google Scholar
  35. Schmidt-Nielsen K (1970) Energy metabolism, body size, and problems of scaling. Fed Proc 29: 1524–1532Google Scholar
  36. Searle GL, Strisower EH, Chaikoff IL (1956) Determination of rates of glucose oxidation in normal and diabetic dogs by a technique involving continuous injection of 14C-glucose. Am J Physiol 185: 589–594Google Scholar
  37. Sloan IG, Sawb PC, Bihler I (1978) Influence of adrenaline on sugar transport in soleus, a red skeletal muscle. Mol Cell Endocrinol 10: 3–12Google Scholar
  38. Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82: 420–430Google Scholar
  39. Therminarias A, Chirpaz MF, Lucas A, Tanche M (1979) Catecholamines in dogs during cold adaptation by repeated immersions. J Appl Physiol 46: 662–668Google Scholar
  40. Valverde I, Dobbs R, Unger RH (1975) Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan diabetic dogs. Metabolism 24: 1021–1028Google Scholar
  41. Vranic M, Kawamori R (1979) Essential roles of insulin and glucagon in regulating glucose fluxes during exercise in dogs. Diabetes [Suppl 1] 28: 45–52Google Scholar
  42. Vranic M, Kawamori R, Pek S, Kovacevic N, Wrenshall GA (1976) The essentiality of insulin and the role of glucagon in regulating glucose turnover during strenuous exercise. J Clin Invest 57: 245–255Google Scholar
  43. Wide L, Porath J (1966) Radioimmunoassay of proteins with the use of Sephadex-coupled antibodies. Biochim Biophys Acta 130: 257–260Google Scholar
  44. Yen SSC, Siler TM, De Vane GW (1974) Effect of somatostatin in patients with acromegaly. Suppression of growth hormone, prolactin, insulin, and glucose levels. New Engl J Med 290: 935–938Google Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • Y. Minaire
    • 1
  • J. Forichon
    • 1
  • G. Dallevet
    • 1
  • M. J. Jomain
    • 1
  1. 1.Laboratoire de Physiologie, Faculté de Médecine Lyon NordCNRS, L.A. 181 et INSERM U 45Lyon, Cédex 2France

Personalised recommendations